Teva-Losartan (2021-08-26)
- Starting date:
- August 26, 2021
- Type of communication:
- Drug Recall
- Subcategory:
- Drugs
- Hazard classification:
- Type I
- Source of recall:
- Health Canada
- Issue:
- Product Safety
- Audience:
- General Public, Healthcare Professionals, Hospitals
- Identification number:
- RA-76341
Last updated:
2021-08-30
Summary
-
Product:
Teva-Losartan
Reason
Presence of Losartan Azide impurity above the acceptable limit.
Affected products
Teva-Losartan
DIN, NPN, DIN-HIM
DIN 02380838
Dosage form
Tablet
Strength
Losartan Potassium 25 Mg
Lot or serial number
0040917
Companies
- Recalling Firm
-
Teva Canada Ltd.
30 Novopharm Court
Toronto
M1B 2K9
Ontario
CANADA
- Marketing Authorization Holder
-
Teva Canada Ltd.
30 Novopharm Court
Toronto
M1B 2K9
Ontario
CANADA
Teva-Losartan
DIN, NPN, DIN-HIM
DIN 02357968
Dosage form
Tablet
Strength
Losartan Potassium 50 Mg
Lot or serial number
1070917, 1020419, 1030419
Companies
- Recalling Firm
-
Teva Canada Ltd.
30 Novopharm Court
Toronto
M1B 2K9
Ontario
CANADA
- Marketing Authorization Holder
-
Teva Canada Ltd.
30 Novopharm Court
Toronto
M1B 2K9
Ontario
CANADA
Teva-Losartan
DIN, NPN, DIN-HIM
DIN 02357976
Dosage form
Tablet
Strength
Losartan Potassium 100 Mg
Lot or serial number
2050419
Companies
- Recalling Firm
-
Teva Canada Ltd.
30 Novopharm Court
Toronto
M1B 2K9
Ontario
CANADA
- Marketing Authorization Holder
-
Teva Canada Ltd.
30 Novopharm Court
Toronto
M1B 2K9
Ontario
CANADA